Why OPKO Health Jumped 13.9% in September

Shares of OPKO Health (NASDAQ: OPK) jumped 13.9% in September, according to data from S&P Global Market Intelligence, after it began its coronavirus vaccine testing program in New York City schools and again following phase 2 testing starting on a COVID-19 treatment.

OPKO's stock plunged over 35% in August after Abbott Labs (NYSE: ABT) announced it would begin offering a cheap, quick COVID-19 test at the end of the month. OPKO's BioReference Labs offers a slightly slower test that takes 24 to 72 hours to see results.

Image source: Getty Images.

Continue reading

Source Fool.com